跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 404 条关于
“Enterotoxigenic Bacteroides fragilis”
全部
404
临床试验
339
药物
23
机构
0
资讯
42
3个月前
How a Gut Bacterium Rewires Colon Cells to Fuel Colitis and Colorectal Cancer
2个月前
Gut Microbiome Metabolites Emerge as Key Modulators of Immune Checkpoint Inhibitor Efficacy and Toxicity
去年
Gut Microbiome Composition Influences Tamoxifen Response in Breast Cancer Patients
去年
Immuron's Travelan Shows Promise in Phase 2 Trial for Traveler's Diarrhea
去年
Intratumoral Microbiota Emerges as Key Player in Cancer Development and Treatment Response
去年
Fecal Microbiota Transplantation Shows Promise in IgA Nephropathy Treatment
2年前
Immuron Announces Positive Results for Travelan®, Progressing to Phase 3 Clinical Trials in the US
6个月前
ETVAX Oral Vaccine Shows Promise Against Deadly E. Coli Infections in Children
7年前
FDA Approves Merck's Recarbrio for Complex Infections with Antimicrobial Stewardship Focus
7个月前
Fecal Microbiota Transplantation Shows Promise in Enhancing Cancer Immunotherapy Across Multiple Tumor Types
第 1 页，共 5 页
上一页
下一页
